Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook

INTRODUCTION: Despite maximal surgical resection and chemoradiation, glioblastoma (GBM) continues to be associated with significant morbidity and mortality. Novel therapeutic strategies are urgently needed. Given success in treating multiple other forms of cancer, checkpoint inhibitor immunotherapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Expert Rev Clin Pharmacol
Hlavní autoři: Gedeon, Patrick C., Champion, Cosette D., Rhodin, Kristen E., Woroniecka, Karolina, Kemeny, Hanna R., Bramall, Alexa N., Bernstock, Joshua D., Choi, Bryan D., Sampson, John H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658017/
https://ncbi.nlm.nih.gov/pubmed/32862726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2020.1817737
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky